C57BL/6JCya-Trim14em1/Cya
Common Name
Trim14-KO
Product ID
S-KO-14507
Backgroud
C57BL/6JCya
Strain ID
KOCMP-74735-Trim14-B6J-VA
When using this mouse strain in a publication, please cite “Trim14-KO Mouse (Catalog S-KO-14507) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Trim14-KO
Strain ID
KOCMP-74735-Trim14-B6J-VA
Gene Name
Product ID
S-KO-14507
Gene Alias
5830400N10Rik, pub
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 4
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000046897
NCBI RefSeq
NM_029077
Target Region
Exon 3~4
Size of Effective Region
~2.7 kb
Overview of Gene Research
TRIM14, an interferon-stimulated gene, is a member of the TRIM family involved in ubiquitination modifications. It plays crucial roles in innate immune responses, especially in pathways like cGAS/STING, PI3K/Akt, and NF-κB, and is widely expressed in various tissues [2].
In innate immunity, Trim14-/-mice are highly susceptible to lethal HSV-1 infection as knockout of TRIM14 impairs HSV-1-triggered antiviral responses in a cGAS-dependent manner. TRIM14 inhibits cGAS degradation mediated by p62-dependent selective autophagy, stabilizing cGAS and promoting type I interferon signaling [1]. In cancer, knockdown of TRIM14 in melanoma cells suppressed cell proliferation, migration, invasion, and melanin synthesis, suggesting it may be a target for melanoma treatment. In breast cancer, reducing TRIM14 inhibited cell proliferation and increased apoptosis [3,5]. In chronic inflammatory pain, Trim14 was elevated in the serum of osteoarthritis patients, and its knockdown in rats relieved pain behaviors, indicating it may be a therapeutic target for chronic inflammatory pain [4].
In summary, TRIM14 is essential for innate immune responses, especially in antiviral defense. Gene-knockout models, such as Trim14-/-mice, have revealed its role in various disease conditions including viral infections, cancer, and chronic inflammatory pain, providing potential therapeutic targets for these diseases.
References:
1. Chen, Meixin, Meng, Qingcai, Qin, Yunfei, Wang, Rong-Fu, Cui, Jun. 2016. TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses. In Molecular cell, 64, 105-119. doi:10.1016/j.molcel.2016.08.025. https://pubmed.ncbi.nlm.nih.gov/27666593/
2. Li, Xinhao, Zhou, Feilong, Niu, Kaiyi, Chen, Tianyi, Zhang, Yewei. 2024. Emerging discoveries on the role of TRIM14: from diseases to immune regulation. In Cell death discovery, 10, 513. doi:10.1038/s41420-024-02276-w. https://pubmed.ncbi.nlm.nih.gov/39719450/
3. Chen, Jiangyan, Huang, Lin, Quan, Jin, Xiang, Debing. 2021. TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways. In Aging, 13, 13225-13238. doi:10.18632/aging.203003. https://pubmed.ncbi.nlm.nih.gov/33982666/
4. Niu, Zheng, Qu, Shu-Ting, Zhang, Ling, Xu, Zhen-Hua, Zhang, Hai-Long. 2024. Trim14-IκBα Signaling Regulates Chronic Inflammatory Pain in Rats and Osteoarthritis Patients. In Neuroscience, 548, 39-49. doi:10.1016/j.neuroscience.2024.04.015. https://pubmed.ncbi.nlm.nih.gov/38697463/
5. Hu, Gaowu, Pen, Wei, Wang, Ming. 2018. TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis. In Oncology research, 27, 439-447. doi:10.3727/096504018X15214994641786. https://pubmed.ncbi.nlm.nih.gov/29562956/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
